medigraphic.com
Colegio de Medicina Interna de México.

2021, Number 3

<< Back Next >>

Med Int Mex 2021; 37 (3)

Diabetes mellitus 2 and COVID-19, two pandemics in symbiosis favored by obesity

Del Carpio-Orantes L, Dorantes-Nava CL

Language: Spanish
References: 17
Page: 407-410
PDF size: 172.72 Kb.


ABSTRACT

This paper reviews the diabetes mellitus pandemic that is ravaging the world, as well as the current COVID-19 pandemic, its links and symbiotic potential in which both are favored to continue affecting the world population, also having an important predisposing factor: obesity, which has reached critical figures in various countries, which favors a vicious circle between obesity and diabetes, which, in turn, favors pandemic scenarios.


REFERENCES

  1. International Diabetes Federation. IDF Diabetes Atlas, 9th ed. Brussels, Belgium: 2019. Available at: https://www. diabetesatlas.org.

  2. Machado-Villarroel L, Montano-Candia M, Dimakis-Ramírez DA. Diabetes mellitus y su impacto en la etiopatogenia de la sepsis. Acta Méd Grupo Ángeles 2017; 15 (3): 207-215.

  3. Bornstein SR, Rubino F, Khunti K, Mingrone G, et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol 2020; 8 (6): 546‐550. doi. 10.1016/S2213-8587(20)30152-2.

  4. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323 (13): 1239-1242. doi. 10.1001/ jama.2020.2648.

  5. Rodríguez-Morales AJ, Cardona-Ospina JA, Gutiérrez- Ocampo E, Villamizar-Peña R, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis 2020; 34: 101623. doi. 10.1016/j.tmaid.2020.101623.

  6. Rhee EJ, Kim JH, Moon SJ, Lee WY. Encountering COVID-19 as Endocrinologists. Endocrinol Metab 2020; 35: e1.

  7. Yang X, Yu Y, Xu J, Shu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020. doi. 10.1016/ S2213-2600(20)30079-5.

  8. World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) [Internet]. 2020. Disponible en: https://www.who.int/docs/ defaultsource/coronaviruse/who-china-joint-mission-oncovid- 19-final-report.pdf.

  9. Kang YJ. Mortality rate of infection with COVID-19 in Korea from the perspective of underlying disease. Disaster Med Public Health Prep. 2020. doi. 10.1017/dmp.2020.60.

  10. Gentile S, Strollo F, Ceriello A. COVID-19 infection in Italian people with diabetes: lessons learned for our future (an experience to be used). Diabetes Res Clin Pract 2020; 162: 108137.

  11. Informe nº 33. Análisis de los casos de COVID-19 notificados a la RENAVE hasta el 10 de mayo en España a 29 de mayo de 2020. Equipo COVID-19. RENAVE. CNE. CNM (ISCIII).

  12. Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, et al. Covid- 19 in critically ill patients in the Seattle region - Case series. N Engl J Med 2020; 382 (21): 2012‐2022. doi. 10.1056/NEJMoa2004500.

  13. CDC COVID-19 Response Team. Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020. MMWR Morb Mortal Wkly Rep 2020; 69 (13): 382‐386. doi. 10.15585/mmwr.mm6913e2.

  14. Aggarwal S, Garcia-Telles N, Aggarwal G, Lavie C, et al. Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States. Diagnosis (Berl) 2020; 7 (2): 91‐96. doi. 10.1515/dx-2020-0046.

  15. Gobierno de México, Dirección General de Epidemiología, 28/05/2020. https://www.gob.mx/salud/documentos/ datos-abiertos-152127.

  16. Escalera-Antezana JP, Lizon-Ferrufino NF, Maldonado-Alanoca A, Alarcón-De la Vega G, et al. Clinical features of the first cases and a cluster of Coronavirus Disease 2019 (COVID-19) in Bolivia imported from Italy and Spain. 2020. Travel Med Infect Dis 2020; 101653. doi. 10.1016/j.tmaid.2020.101653.

  17. Escobar G, Matta J, Taype W, Ayala R, Características clínicoepidemiológicas de pacientes fallecidos por COVID-19 en un hospital nacional de Lima, Perú. Rev Fac Med Hum 2020; 20 (2): 180-185. doi. 10.25176/RFMH.v20i2.2940.




2020     |     www.medigraphic.com